Sigyn Therapeutics, Inc. (SIGY)

USD 3.15

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - 143.32 Thousand 28.34 Thousand
Cost of Revenue 8856.00 10.45 Thousand 536.05 11.3 Thousand 35.66 Thousand 9712.00
Gross Profit -8856.00 -10.45 Thousand -536.05 -11.3 Thousand 107.65 Thousand 18.63 Thousand
Operating Expenses 2.45 Million 2.14 Million 2 Million 916.43 Thousand 625.61 Thousand 1.02 Million
Selling, General and Administrative Expenses 1.65 Million 1.48 Million 1.27 Million 888.97 Thousand 625.61 Thousand 1.02 Million
Research and Development Expenses 798.16 Thousand 657.65 Thousand 734.01 Thousand 27.45 Thousand - -
Other Expenses - - -536.05 Thousand - - 105.26 Thousand
Cost and Expenses 2.45 Million 2.14 Million 2 Million 916.43 Thousand 661.28 Thousand 1.03 Million
Operating Income -2.45 Million -2.14 Million -2 Million -916.43 Thousand -517.95 Thousand -1 Million
Interest Expense 2.04 Million 646.74 Thousand 399.07 Thousand 343.15 Thousand 55.2 Thousand 352.83 Thousand
Income Tax Expense - 782.11 Thousand 399.07 Thousand 343.15 Thousand -183.11 Thousand 800.00
Earnings before Tax -4.14 Million -2.92 Million -3 Million -1.25 Million -3.31 Million -2.3 Million
Net Income -4.14 Million -3.71 Million -3.4 Million -1.6 Million -3.12 Million -2.62 Million
Earnings Per Share Basic -3.77 -3.97 -0.09 -0.22 -5.78 -6.04
Earnings Per Share Diluted -3.77 -3.97 -0.09 -0.22 -5.78 -6.04
Weighted Average Shares Outstanding 1.1 Million 934 Thousand 36.39 Million 7.35 Million 541.84 Thousand 433.82 Thousand
Weighted Average Shares Outstanding (Diluted) 1.1 Million 934 Thousand 36.39 Million 7.35 Million 541.84 Thousand 433.82 Thousand
Gross Margin - - - - 0.75 0.66
EBIT Margin - - - - -3.09 -26.72
Profit Margin - - - - -21.84 -92.43
EBITDA -2.44 Million -2.13 Million -2.52 Million -905.13 Thousand -442.63 Thousand -1.7 Million
Earnings Before Tax Margin - - - - -3.61 -35.44

Income Statement Charts